Alembic Pharma receives USFDA tentative approval for Binimetinib tablets
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Over 28 crore people screened, TB incidence falls sharply as Centre urges states to intensify efforts ahead of July campaign deadline
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
Study will assess the safety and effectiveness of irreversible electroporation as a minimally invasive treatment option for benign prostatic hyperplasia (BPH)
LV Prasad Eye Institute founder recognized for his pioneering contribution to affordable and accessible eye care; award celebrates two decades of honoring transformative humanitarian leadership.
Findings show growing optimism across the pharma sector as dealmaking accelerates, innovation strengthens, and companies adapt to tariffs, pricing reforms, and looming patent expirations
New facility equipped with advanced imaging technology to support 200 additional procedures a month and benefit nearly 3,000 more patients annually
New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad
Subscribe To Our Newsletter & Stay Updated